Cibc World Market Inc. bought a new stake in IDEX Corporation (NYSE:IEX – Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 15,712 shares of the industrial products company’s stock, valued at approximately $3,566,000.
A number of other institutional investors have also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in IDEX during the second quarter worth about $1,301,393,000. Primecap Management Co. CA lifted its stake in shares of IDEX by 86.5% in the 4th quarter. Primecap Management Co. CA now owns 3,226,787 shares of the industrial products company’s stock valued at $574,174,000 after purchasing an additional 1,496,207 shares in the last quarter. Dodge & Cox grew its holdings in shares of IDEX by 266.7% during the 4th quarter. Dodge & Cox now owns 1,262,550 shares of the industrial products company’s stock worth $224,658,000 after purchasing an additional 918,208 shares during the period. Norges Bank purchased a new stake in shares of IDEX during the 4th quarter worth about $162,788,000. Finally, Millennium Management LLC increased its position in IDEX by 293.6% during the 4th quarter. Millennium Management LLC now owns 1,063,763 shares of the industrial products company’s stock worth $189,286,000 after purchasing an additional 793,530 shares in the last quarter. Hedge funds and other institutional investors own 97.96% of the company’s stock.
Insider Activity at IDEX
In other news, CAO Lisa M. Anderson sold 385 shares of the company’s stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $238.59, for a total value of $91,857.15. Following the completion of the transaction, the chief accounting officer directly owned 4,327 shares in the company, valued at approximately $1,032,378.93. This represents a 8.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.50% of the company’s stock.
IDEX Price Performance
IDEX (NYSE:IEX – Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The industrial products company reported $2.32 EPS for the quarter, topping the consensus estimate of $2.11 by $0.21. The firm had revenue of $920.60 million for the quarter, compared to analyst estimates of $905.38 million. IDEX had a return on equity of 15.69% and a net margin of 14.49%.IDEX’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the previous year, the company posted $2.07 EPS. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS. On average, equities analysts predict that IDEX Corporation will post 8.82 earnings per share for the current fiscal year.
IDEX Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, July 24th. Stockholders of record on Monday, July 6th were given a dividend of $0.73 per share. This represents a $2.92 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date of this dividend was Monday, July 6th. IDEX’s payout ratio is presently 42.01%.
Analyst Upgrades and Downgrades
IEX has been the topic of several research reports. Robert W. Baird set a $257.00 price target on shares of IDEX in a report on Thursday, April 30th. Mizuho raised shares of IDEX from a “neutral” rating to an “outperform” rating and increased their price objective for the stock from $210.00 to $280.00 in a research report on Tuesday, August 11th. Weiss Ratings raised shares of IDEX from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, July 30th. Stifel Nicolaus lifted their target price on shares of IDEX from $257.00 to $268.00 and gave the company a “buy” rating in a report on Thursday, July 30th. Finally, Royal Bank Of Canada lifted their target price on shares of IDEX from $261.00 to $280.00 and gave the company an “outperform” rating in a report on Thursday, July 30th. Eight investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, IDEX presently has a consensus rating of “Moderate Buy” and a consensus target price of $260.80.
View Our Latest Analysis on IEX
Key IDEX News
Here are the key news stories impacting IDEX this week:
- Positive Sentiment: Zacks increased its FY2026 EPS estimate to $8.71 from $8.70, Q4 2026 to $2.20 from $2.18, and Q1 2027 to $2.12 from $2.11.
- Positive Sentiment: Longer-term estimates also improved: FY2027 EPS rose to $9.26 from $9.21, Q4 2027 to $2.42 from $2.38, Q1 2028 to $2.38 from $2.36, and FY2028 to $10.54 from $10.45. The revisions imply continued earnings growth, although the increases were relatively small.
- Positive Sentiment: The revised FY2026 estimate of $8.71 remains close to the broader analyst consensus of $8.82. IDEX’s latest reported quarter also showed earnings and revenue ahead of expectations, with EPS of $2.32 and revenue of $920.6 million, up 6.4% year over year.
- Neutral Sentiment: The six Zacks updates largely repeat the same forecast changes rather than representing separate fundamental developments. Investors may view them as supportive, but the limited size of the revisions may constrain their impact.
- Neutral Sentiment: IDEX shares have increased and are trading near the upper end of their 52-week range, above both their 50-day and 200-day moving averages. With a market capitalization of approximately $17.3 billion and a forward-looking valuation near 27 times earnings, further gains may depend on the company converting the raised forecasts into actual results.
- Neutral Sentiment: A separate report concerns IDEX Biometrics ASA (OTC: IDXAF), which granted incentive subscription rights to two senior employees. That company is unrelated to IDEX Corporation and should not affect IEX shares. IDEX Biometrics executive incentive rights announcement
IDEX Company Profile
IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.
Operations at IDEX are organized into three principal segments.
See Also
- Five stocks we like better than IDEX
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding IEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IDEX Corporation (NYSE:IEX – Free Report).
Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.
